#BEGIN_DRUGCARD DB01817

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H16N2O6

# Chemical_IUPAC_Name:
(2R,3S)-2-amino-3-[(1S,3S)-3-amino-3-carboxy-1-hydroxypropoxy]butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Threonine-Aspartic Ester

# HET_ID:
AEI

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H16N2O6/c1-3(6(10)8(14)15)16-5(11)2-4(9)7(12)13/h3-6,11H,2,9-10H2,1H3,(H,12,13)(H,14,15)/t3-,4-,5-,6+/m0/s1

# InChI_Key:
InChIKey=VCAYFLVMRCFGDV-OMMKOOBNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1817

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
236.2224

# Molecular_Weight_Mono:
236.100836254

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
4ECA

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-4.2

# Predicted_LogS:
-0.92

# Predicted_Water_Solubility:
2.81e+01 g/l

# Primary_Accession_No:
DB01817

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936226

# PubChem_Substance_ID:
46508943

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00445

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@H](O[C@H](O)C[C@H](N)C(O)=O)[C@@H](N)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:31 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M34277

# Drug_Target_1_GenBank_ID_Protein:
146597

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ansB

# Drug_Target_1_Gene_Sequence:
>1047 bp
ATGGAGTTTTTCAAAAAGACGGCACTTGCCGCACTGGTTATGGGTTTTAGTGGTGCAGCA
TTGGCATTACCCAATATCACCATTTTAGCAACCGGCGGGACCATTGCCGGTGGTGGTGAC
TCCGCAACCAAATCTAACTACACAGTGGGTAAAGTTGGCGTAGAAAATCTGGTTAATGCG
GTGCCGCAACTAAAAGACATTGCGAACGTTAAAGGCGAGCAGGTAGTGAATATCGGCTCC
CAGGACATGAACGATAATGTCTGGCTGACACTGGCGAAAAAAATTAACACCGACTGCGAT
AAGACCGACGGCTTCGTCATTACCCACGGTACCGACACGATGGAAGAAACTGCTTACTTC
CTCGACCTGACGGTGAAATGCGACAAACCGGTGGTGATGGTCGGCGCAATGCGTCCGTCC
ACGTCTATGAGCGCAGACGGTCCATTCAACCTGTATAACGCGGTAGTGACCGCAGCTGAT
AAAGCCTCCGCCAACCGTGGCGTGCTGGTAGTGATGAATGACACCGTGCTTGATGGCCGT
GACGTCACCAAAACCAACACCACCGACGTAGCGACCTTCAAGTCTGTTAACTACGGTCCT
CTGGGTTACATTCACAACGGTAAGATTGACTACCAGCGTACCCCGGCACGTAAGCATACC
AGCGACACGCCATTCGATGTCTCTAAGCTGAATGAACTGCCGAAAGTCGGCATTGTTTAT
AACTACGCTAACGCATCCGATCTTCCGGCTAAAGCACTGGTAGATGCGGGCTATGATGGC
ATCGTTAGCGCTGGTGTGGGTAACGGCAACCTGTATAAATCTGTGTTCGACACGCTGGCG
ACCGCCGCGAAAACCGGTACTGCAGTCGTGCGTTCTTCCCGCGTACCGACGGGCGCTACC
ACTCAGGATGCCGAAGTGGATGATGCGAAATACGGCTTCGTCGCCTCTGGCACGCTGAAC
CCGCAAAAAGCGCGCGTTCTGCTGCAACTGGCTCTGACGCAAACCAAAGATCCGCAGCAG
ATCCAGCAGATCTTCAATCAGTACTAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
1287659	Derst C, Henseling J, Rohm KH: Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis. Protein Eng. 1992 Dec;5(8):785-9.
1521538	Wehner A, Harms E, Jennings MP, Beacham IR, Derst C, Bast P, Rohm KH: Site-specific mutagenesis of Escherichia coli asparaginase II. None of the three histidine residues is required for catalysis. Eur J Biochem. 1992 Sep 1;208(2):475-80.
1906013	Harms E, Wehner A, Aung HP, Rohm KH: A catalytic role for threonine-12 of E. coli asparaginase II as established by site-directed mutagenesis. FEBS Lett. 1991 Jul 8;285(1):55-8.
2144836	Bonthron DT: L-asparaginase II of Escherichia coli K-12: cloning, mapping and sequencing of the ansB gene. Gene. 1990 Jul 2;91(1):101-5.
2407723	Jennings MP, Beacham IR: Analysis of the Escherichia coli gene encoding L-asparaginase II, ansB, and its regulation by cyclic AMP receptor and FNR proteins. J Bacteriol. 1990 Mar;172(3):1491-8.
321449	Peterson RG, Richards FF, Handschumacher RE: Structure of peptide from active site region of Escherichia coli L-asparaginase. J Biol Chem. 1977 Mar 25;252(6):2072-6.
387570	Maita T, Morokuma K, Matsuda G: Amino acid sequences of the tryptic peptides from carboxymethylated L-asparaginase from Escherichia coli. Hoppe Seylers Z Physiol Chem. 1979 Oct;360(10):1483-95.
4561256	Greenquist AC, Wriston JC Jr: Chemical evidence for identical subunits in L-asparaginase from Escherichia coli B. Arch Biochem Biophys. 1972 Sep;152(1):280-6.
6766894	Maita T, Matsuda G: The primary structure of L-asparaginase from Escherichia coli. Hoppe Seylers Z Physiol Chem. 1980;361(2):105-17.
8434007	Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A: Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1474-8.
8706862	Palm GJ, Lubkowski J, Derst C, Schleper S, Rohm KH, Wlodawer A: A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant. FEBS Lett. 1996 Jul 22;390(2):211-6.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2465

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
36851

# Drug_Target_1_Name:
L-asparaginase 2

# Drug_Target_1_Number_of_Residues:
348

# Drug_Target_1_PDB_ID:
1NNS

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00710	Asparaginase

# Drug_Target_1_Protein_Sequence:
>L-asparaginase 2 precursor
MEFFKKTALAALVMGFSGAALALPNITILATGGTIAGGGDSATKSNYTVGKVGVENLVNA
VPQLKDIANVKGEQVVNIGSQDMNDNVWLTLAKKINTDCDKTDGFVITHGTDTMEETAYF
LDLTVKCDKPVVMVGAMRPSTSMSADGPFNLYNAVVTAADKASANRGVLVVMNDTVLDGR
DVTKTNTTDVATFKSVNYGPLGYIHNGKIDYQRTPARKHTSDTPFDVSKLNELPKVGIVY
NYANASDLPAKALVDAGYDGIVSAGVGNGNLYKSVFDTLATAAKTGTAVVRSSRVPTGAT
TQDAEVDDAKYGFVASGTLNPQKARVLLQLALTQTKDPQQIQQIFNQY

# Drug_Target_1_Reaction:
L-asparagine + H2O = L-aspartate + NH3

# Drug_Target_1_Signals:
1-22

# Drug_Target_1_Specific_Function:
L-asparagine + H(2)O = L-aspartate + NH(3)

# Drug_Target_1_SwissProt_ID:
P00805

# Drug_Target_1_SwissProt_Name:
ASPG2_ECOLI

# Drug_Target_1_Synonyms:
Colaspase
EC 3.5.1.1
L- asparagine amidohydrolase II
L-ASNase II
L-asparaginase 2 precursor
L-asparaginase II

# Drug_Target_1_Theoretical_pI:
6.29

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01817
